MedPath

RYMTI

RYMTI

Approved
DIN Number

02530287

Drug Class

Human

Market Date

N/A

Company
HC

lupin pharma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02530287
AIG Number0151564001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AB01 ETANERCEPT
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ETANERCEPTActive
Strength: 25 MG / 0.5 ML
Monograph: ETANERCEPT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.